International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Founded in 1968, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents research-based biopharmaceutical industry. Members comprise of leading international companies as well as national and regional associations across the globe. The organization brings the industry and broader health community together to foster innovation, promote resilient regulatory systems and high standards of quality, uphold ethical practices, and advocate sustainable health policies to meet global needs.

The IFPMA corporate website is a comprehensive information resource. Additionally, the IFPMA Health Partnerships Directory is the largest international database for health development programs involving the research-based biopharmaceutical industry.

A full list of the IFPMA's members is available on the corporate website.

Get RSS feed of these results

Related stories and components

Article
5 May 2011

[PDF] R&D Pharmaceutical Industry Perspective on Specifications for Paediatric Medicines

Author: Tom Sam, Rebecca Stevens, International Federation of Pharmaceutical Manufacturers & Associations

Challenges for the global research and development of pediatric medicines are technical, ethical and financial. Early collaboration among all stakeholders is required to identify treatments to be developed and how to develop them…A balanced approach...

Read more

Article
13 May 2009

[PDF] Report of the Partners Meeting on Better Medicines for Children

Author: WHO

This report provides a…summary of discussions held at the first WHO' Partner's meeting on work on Better Medicines for Children. The purpose of the meeting was to provide an opportunity for interested stakeholders…to be informed about WHO's activities...

Read more

Article
1 April 2008

[PDF] Corporate Responsibilities for Access to Medicines

Author: Klaus Leisinger, Novartis Foundation for Sustainable Development

There is today a growing wave of demands being placed upon the pharmaceutical industry to contribute to improved access to medicines for poor patients in the developing countries. This paper aims to contribute to the development of a systematic...

Read more

Article
4 December 2007

R&D Pharmaceutical Industry Intensifies Efforts To Address HIV/AIDS Threat, Including Resistance & Pediatric Needs

Author: Medical News Today [UK]

On the important occasion of World AIDS Day on 1 December 2007, the International Federation of Pharmaceutical Manufacturers & Associations has underlined the research-based pharmaceutical industry's commitment to address HIV/AIDS. The industry's...

Read more

Article
30 January 2007

Activists praise, drug industry criticizes Thailand's decision to ignore patents

Author: AP

Thailand's decision to break the patents on two major commercial drugs to allow the sale of cheaper generic versions was applauded Tuesday by health activists but questioned by the pharmaceutical industry. On Monday, Thai Public Health Minister...

Read more

Article
29 January 2007

Thailand Allows Copycat Pharmaceuticals

Author: Pongpiphat Banchanont, Reuters

Thailand's army-appointed government confirmed on Monday it approved a cheap, copycat version of a blockbuster heart disease drug, the first time a developing country has torn up the international patent for such a treatment. In addition to the ...

Read more

Article
4 December 2006

U.N. health agency launches pharmaceutical review

Author: Laura MacInnis, Reuters

The World Health Organization launched its first intergovernmental review of the pharmaceutical sector to try to find ways of making medicine more easily available to the world's poorest people. In their five-day talks, the WHO's 193 member countries...

Read more

Article
1 December 2006

Pharmaceutical Industry Fails in Developing Industry-Wide HIV/AIDS Initiative

Author: International Federation of Chemical, Energy, Mine and General Workers' Unions

Today, on World AIDS Day, 1 December, ICEM General Secretary Fred Higgs announced the collapse of talks on a promising global HIV/AIDS initiative which had the potential to save countless lives of those living with HIV/AIDS in the world’s least...

Read more

Article
12 October 2006

'Greedy' drugs industry struggles to polish image

Author: Ben Hirschler, Reuters So. Africa

The global drugs industry, battered by controversy over drug safety and access to medicines, needs to go on the offensive to demonstrate its value to society, top executives said on Thursday. Daniel Vasella, Chief Executive of Novartis AG and outgoing...

Read more

  • Related companies: Merck
Article
7 April 2006

IFPMA Welcomes World Health Day Call To Build Strong Healthcare Workforces, Especially In Developing Countries

Author: International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Dr. Harvey E. Bale, Director-General of the IFPMA [International Federation of Pharmaceutical Manufacturers & Associations], said:...“Looking at HIV/AIDS, which has been the pandemic targeted most by the WHO,...countries most severely affected are...

Read more